Antidepressants cause foot detachment from substrate in five species of marine snail

Marine Environmental Research

Volumn 84, Issue , 2013, Pages 24-30

  Fong, Peter P ^a   Molnar, Nikolett ^b  

^a GETTYSBURG COLLEGE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antidepressant; Aquatic; Ecotoxicology; Environmental toxicology; Gastropod; Locomotion; Marine ecology; Molluscs; Snails

Indexed keywords

ANTIDEPRESSANT; AQUATIC; ECO-TOXICOLOGY; ENVIRONMENTAL TOXICOLOGY; GASTROPOD; MARINE ECOLOGY; MOLLUSCS; SNAILS;

BIPED LOCOMOTION; ECOSYSTEMS; EFFLUENTS; SEWAGE; SUBSTRATES;

ANIMALS;

CITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; VENLAFAXINE;

DOSE-RESPONSE RELATIONSHIP; DRUG; ECOTOXICOLOGY; LOCOMOTION; SNAIL; WASTEWATER;

ARTICLE; ATLANTIC OCEAN; CHLOROSTOMA FUNEBRALIS; CONTROLLED STUDY; ECOTOXICITY; LITHOPOMA AMERICANUM; MARINE SNAIL; NONHUMAN; NUCELLA OSTRINA; PACIFIC OCEAN; TEGULA FASCIATUS; UROSALPINX CINEREA;

ANIMALS; ANTIDEPRESSIVE AGENTS; AQUATIC ORGANISMS; NORTH AMERICA; SNAILS; WATER POLLUTANTS, CHEMICAL;

ATLANTIC COAST [NORTH AMERICA]; PACIFIC COAST [NORTH AMERICA];

APIS; BASOMMATOPHORA; CHLOROSTOMA; GASTROPODA; LITHOPOMA; LITHOPOMA AMERICANUM; MOLLUSCA; MURICIDAE; NUCELLA OSTRINA; TEGULA; TROCHIDAE; TURBINIDAE; UROSALPINX CINEREA;

EID: 84873097410     PISSN: 01411136     EISSN: 18790291     Source Type: Journal    
DOI: 10.1016/j.marenvres.2012.11.004     Document Type: Article

References (63)

1. Benotti M.J., Brownawell B.J. Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ. Sci. Technol. 2007, 41:5795-5802.
2. Black, M., Armbrust, K., 2007. The Environmental Occurrence, Fate, and Ecotoxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Aquatic Environments. Final Report, United States Environmental Protection Agency.
3. Brausch J.M., Connors K.A., Brooks B.W., Rand G.M. Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Rev. Environ. Contam. Toxicol. 2012, 218:1-99.
4. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142:169-183.
5. Brooks B.W., Turner P.K., Stanley J.K., Weston J.J., Glidewell E.A., Foran C.M., Slattery M., La Point T.W., Huggett D.B. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 2003, 52:135-142.
6. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
7. Chen M., Ohman K., Metcalfe C., Ikonomou M.G., Amatya P., Wilson J. Pharmaceuticals and endocrine disruptors in wastewater treatment effluent and in the water supply system of Calgary, Alberta, Canada. Water Qual. Res. J. Can. 2006, 41(4):351-364.
8. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 2003, 142:185-194.
9. Choong A.M.F., Teo S.L.-M., Leow J.L., Koh H.L., Ho P.C.L. A preliminary ecotoxicity study of pharmaceuticals in the marine environment. J. Toxicol. Environ. Health (A) 2006, 69:1959-1970.
10. Cunha E.M., Machado J. Parturition in Anodonta cygnea induced by selective serotonin reuptake inhibitors (SSRIs). Can. J. Zool. 2001, 79:95-100.
11. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(Suppl. 6):907-938.
12. Daughton C.G., Jones-Lepp T.L. Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. Symposium Series 791 2001, American Chemical Society, Washington, D.C.
13. Daughton C.G., Brooks B.W. Active pharmaceutical ingredients and aquatic organisms. Environmental Contaminants in Biota: Interpreting Tissue Concentrations 2011, 286-347. CRC Press, Taylor and Francis, Boca Raton, Florida. second ed. W.N. Beyer, J.P. Meador (Eds.).
14. Denny M.W., Gaines S.D. Encyclopedia of Tidepools and Rocky Shores 2007, University of California Press, Berkeley, California, USA.
15. Downing C. Photolysis of Venlafaxine and Paroxetine in Aqueous Solutions. Report to the College of Saint Benedict and Saint John's University 2004, 8 pp.
16. Faccioni-Heuser M.C., Zancan D.M., Achaval M. Monoamines in the pedal plexus of the land snail Megalobulimus oblongus (Gastropoda, Pulmonata). Braz. J. Med. Biol. Res. 2004, 37(7):1043-1053.
17. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicol. 2006, 76:122-159.
18. Fong P.P. Zebra mussel spawning is induced in low concentrations of putative selective serotonin reuptake inhibitors. Biol. Bull. 1998, 194:143-149.
19. Fong P.P., Hoy C.M. Antidepressants (venlafaxine and citalopram) cause foot detachment from the substrate in freshwater snails at environmentally relevant concentrations. Mar. Behav. Physiol. 2012, 45(2):145-153.
20. Frankovich T.A., Zieman J.C. A temporal investigation of grazer dynamics, nutrients, seagrass leaf productivity, and epiphyte standing stock. Estuaries 2005, 28:39-50.
21. Gaworecki K.M., Klaine S.J. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquatic Toxicol. 2008, 88:207-213.
22. Gelsleichter J. Evaluating the Risks that Pharmaceutical-related Pollutants Pose to Caloosahatchee River Wildlife: Observations on the Bull Shark, Carcharhinus Leucas. Final Report Charlotte Harbor National Estuary Program 2009, 16 pp.
23. Harrold K.H., Yee D., Sedlak M., Klosterhaus S., Davis J.A., Woudneh M., Riley P. Pharmaceutical Concentrations in Wastewater Treatment Plant Influent and Effluent and Surface Waters of Lower South San Francisco Bay. SFEI Contribution 549 2009, San Francisco Estuary Institute, Oakland, CA.
24. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
25. Henry T.B., Kwon J.-W., Armbrust K.L., Black M.C. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ. Toxicol. Chem. 2004, 23:2229-2233.
26. Holomuzki J.R., Biggs B.J.F. Distributional responses to flow disturbance by a stream-dwelling snail. Oikos 1999, 87:36-47.
27. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-Blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 2002, 43:229-235.
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Tech. 2002, 36:1202-1211.
29. Kolpin D.W., Skopec M., Meyer M.T., Furlong E.T., Zaugg S.D. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci. Total Environ. 2004, 328:119-130.
30. Kwon J.-W., Armbrust K.L. Degradation of citalopram by simulated sunlight. Environ. Toxicol. Chem. 2005, 24(7):1618-1623.
31. Kwon J.-W., Armbrust K.L. Photo-isomerization of fluvoxamine in aqueous solutions. J. Pharm. Biomed. Anal. 2005, 37(4):643-648.
32. Kwon J.-W., Armbrust K.L. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ. Toxicol. Chem. 2006, 25(10):2561-2568.
33. Lemmnitz G. Neuromotor bases of the escape behavior of Nassa mutabilis. J. Exp. Biol. 1989, 143:493-507.
34. Lewis S.L., Lyons D.E., Meekins T.L., Newcomb J.M. Serotonin influences locomotion in the nudibranch Melibe leonine. Biol. Bull. 2011, 220:155-160.
35. Mackey S., Carew T.J. Locomotion in Aplysia: triggering by serotonin and modulation by bag cell extract. J. Neurosci. 1983, 3:1469-1477.
36. Madureira T.V., Barreiro J.C., Rocha M.J., Rocha E., Cass Q.B., Tiritan M.E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci. Total Environ. 2010, 408:5513-5520.
37. McClanahan T.R. Epibenthic gastropods of the middle Florida keys: the role of habitat and environmental stress on assemblage composition. J. Exp. Mar. Biol. Ecol. 1992, 160(2):169-190.
38. McKenzie J.D., Caunce M., Hetherington M.S., Winlow W. Serotonergic innervation of the foot of the pond snail Lymnaea stagnalis (L.). J. Neurocytol. 1998, 27:459-470.
39. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29(1):79-89.
40. Miller L.P., O'Donnell M.J., Mach K.J. Dislodged but not dead: survivorship of a high intertidal snail following wave dislodgement. J. Mar Biol. Ass. U. K. 2007, 87:735-739.
41. Moroz L.L., Sudlow L.C., Jing J., Gillette R. Serotonin-immunoreactivity in peripheral tissues of the opisthobranch molluscs Pleurobranchaea californica and Tritonia diomedea. J. Comp. Neurol. 1997, 382:176-188.
42. Morris R.H., Abbott D.P., Haderlie E.C. Intertidal Invertebrates of California 1980, Stanford Univ. Press, 690 pp.
43. Navarrete S.A., Menge B.A., Daley B.A. Species interactions in a rocky intertidal food web: prey or predation regulation of intermediate predators?. Ecology 2000, 81:2264-2277.
44. Paine R.T. The Pisaster-Tegula interaction: prey patches, predator food preference, and intertidal community structure. Ecology 1969, 50:950-961.
45. Painter M.M., Buerkley M.A., Julius M.L., Vajda A.M., Norris D.O., Barber L.B., Furlong E.T., Schultz M.M., Schoenfuss H.L. Antidepressants at environmentally relevantconcentrations affect predator avoidance behaviour of larval fathead minnows (Pimpephales promelas). Environ. Toxicol. Chem. 2009, 28:2677-2684.
46. Pait A.S., Warner R.A., Hartwell S.I., Nelson J.O., Pacheco P.A., Mason A.L. Human Use Phar Maceuticals in the Estuarine Environment: a Survey of the Chesapeake Bay, Biscayne Bay and Gulf of the Farallones. NOS NCCOS 7 2006, NOAA/NOS/NCCOS/Center for Coastal Monitoring and Assessment, Silver Spring, MD, 21 pp.
47. Pavlova G.A. Effects of serotonin, dopamine and ergometrine on locomotion in the pulmonate mollusc Helix lucorum. J. Exp. Biol. 2001, 204:1625-1633.
48. Phillips P.J., Smith S.G., Kolpin D.W., Zaugg S.D., Buxton H.T., Furlong E.T., Esposito E., Stinson B. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ. Sci. Technol. 2010, 44:4910-4916.
49. Richards S.M., Wilson C.J., Johnson D.J., Castle D.M., Lam M., Mabury S.A., Sibley P.K., Solomon K.R. Effects of pharmaceutical mixtures in aquatic microcosms. Environ. Toxicol. Chem. 2004, 23(4):1035-1042.
50. Rittschof D., Williams L.G., Brown B., Carriker M.R. Chemical attraction of newly hatched oyster drills. Biol. Bull. 1983, 164:493-505.
51. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
52. RxList, 2006. Available from: (cited 22 November 2006). http://www.rxlist.com/top200.htm.
53. Sakharov D.A., Salanki J. Effects of dopamine antagonists on snail locomotion. Experientia 1982, 38:1090-1091.
54. Santos L.H.M.L.M., Araujo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazar. Mat. 2010, 175:45-95.
55. Satterlie R.A. Serotonergic modulation of swimming speed in the pteropod mollusc Clione limacina. J. Exp. Biol. 1995, 198:905-916.
56. Seiler J.P. Pharmacodynamic activity of drugs and ecotoxicology-can the two be connected?. Toxicol. Lett. 2002, 131:105-115.
57. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1762.
58. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
59. Schultz M.M., Painter M.M., Bartell S.E., Logue A., Furlong E.T., Werner S.L., Schoenfuss H.L. Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. Aquatic Toxicol. 2011, 104:38-47.
60. Silva L.J.G., Lino C.M., Meisel L.M., Pena A. Selective serotonin re-uptake inhibitors (SSRIs) in the aquatic environment: an ecopharmacovigilance approach. Sci. Total. Environ. 2012, 437:185-195.
61. Styrishave B., Halling-Sorensen B., Ingerslev F. Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario. Environ. Toxicol. Chem. 2011, 30(1):254-261.
62. Weigel S., Urs B., Einar J., Kallenborn R., Thoresen H., Huhnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
63. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J.L. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Esturary and its coastal zone. J. Hazard. Mat. 2011, 190:588-596.